China Reg Express: Gilead, Roche Bag Descovy, Hemlibra OKs, NMPA Joins COPP
Executive Summary
China continues approvals rush, granting green lights for Harvoni, Descovy and Hemlibra, and expands Zytiga's use. Meanwhile, the nation’s top regulatory agency signs an MoU with the Medicines Patent Pool and joins the COPP program.